跳至主要内容
临床试验/KCT0004984
KCT0004984尚未招募未知

Cardiovascular Disease (CVD) Risk Assessment and Lipid Lowering Treatment in Type 2 Diabetes Mellitus Patients Treated at Secondary and/or Tertiary Hospitals in Korea

Pfizer Upjohn Korea0 个研究点目标入组 2,000 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. Adult Type 2 diabetes mellitus patients (=20 years) treated at secondary and/or tertiary hospitals
  • 2. Patients with a record on cholesterol level at the time of enrollment

排除标准

  • 1. Patients currently participating in other drug-controlled interventional study
  • 2. Patients in severe or unstable medical conditions by physicians’ discretion during the recruitment

研究者

发起方
Pfizer Upjohn Korea

相似试验